Table 2.
Crude and adjusted unstandardized multiple linear regression coefficients (SE) for the duration of admission (in days) in the analytic sample (N = 211)
| Model A | Model B | Model C | |
|---|---|---|---|
| Intercept | 147.46 (8.90)** | 159.32 (39.28)** | 133.14 (30.52)** |
| Group 1: Any diagnosis (excluding COSS) with psychotic symptoms | Reference | Reference | Reference |
| (Reference; N = 112; 53.1%) | |||
| Group 2: COSS (N = 20; 9.5%) | 47.20 (28.74) | 50.16 (29.31) | 52.02 (30.52) |
| Group 3: No psychotic symptoms (N = 79; 37.4%) | −28.15 (11.86)* | −27.93 (11.72)* | −23.93 (12.02)* |
| Sex, female (N = 95; 45.0%) | — | −13.79 (13.05) | −9.86 (12.95) |
| Age at admission (months) | — | .06 (.31) | .03 (.31) |
| Number of diagnoses | — | — | 4.07 (6.20) |
| Medication at admission (N = 114–54.0%) | — | — | 21.90 (12.48) |
| CGAS at admission | — | — | .08 (.46) |
Abbrevaitions: COSS, Childhood-onset schizophrenia spectrum disorders; CGAS, Children Global Assessment Scale.
p < 0.05.
p < .0.01.